Published in Biotech Business Week, January 24th, 2005
"We agreed to postpone the closing of a definitive agreement because both parties felt that they should check other opportunities before undertaking the proposed transaction" said Arik Hinkis, president of VDYI.
The 2 companies will continue to discuss the proposed transaction in the coming 3 months. During this period...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.